About the comparison of two anabolic agents, teriparatide and strontium ranelate, in treated osteoporotic women

Journal of Bone and Mineral Research

Volumn 24, Issue 12, 2009, Pages 2066-

  Meunier, Pierre J ^a   Boivin, Georges ^a   Marie, Pierre J ^b  

^a UNIVERSITÉ DE LYON   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; BIOLOGICAL MARKER; CALCITONIN; PARATHYROID HORMONE[1-34]; STRONTIUM RANELATE;

BONE BIOPSY; BONE REMODELING; BONE TURNOVER; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG EFFECT; HORMONE SUBSTITUTION; HUMAN; LETTER; MORPHOMETRICS; PATIENT COMPLIANCE; POROSITY; POSTMENOPAUSE OSTEOPOROSIS; STATISTICAL SIGNIFICANCE;

ANABOLIC AGENTS; FEMALE; HUMANS; ORGANOMETALLIC COMPOUNDS; OSTEOBLASTS; OSTEOPOROSIS; TERIPARATIDE; THIOPHENES;

EID: 73849146219     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090903     Document Type: Letter

References (4)

1. Recker RR, Marin F, Ish-Shalom S, Möricke R, Hawkins F, Kapetanos G, de la Peña MP, Kekow J, Farrerons J, Sanz B, Oertel H, Stepan J 2009 Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis. J Bone Miner Res 24:1358-1368.
2. Arlot ME, Jiang Y, Genant HK, Zhao J, Burt-Pichat B, Roux JP, Delmas PD, Meunier PJ 2008 Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate. J Bone Miner Res 23:215-222.
3. Marie PJ, Hott M, Modrowski D, De PC, Guillemain J, Deloffre P, Tsouderos Y 1993 An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8:607-615.
4. Bain SD, Jerome C, Shen V, Dupin-Roger I, Ammann P 2009 Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants. Osteoporos Int 20:1417-1428.